Unlocking Microcap Alpha: 2024 Highlights and 2025 Insights with Maj Soueidan & Bobby Kraft [GeoWire Weekly No. 169]
Welcome to The GeoWire , your source for a Peek into GeoInvesting’s Research Coverage, Microcap Stock Education, Case Studies, Featured Videos, and More. Please share this if you like today’s newsletter and comment with any feedback.
If you are new or this was shared with you, you can join our email list here.
For real time analysis of our coverage universe, including new high conviction ideas and additions to our model portfolios, if you are not already a premium subscriber, consider supporting our movement by becoming a premium member today. GeoInvesting, 16 years and counting!
If you are a premium member make sure you sign in to see All the exclusive content In This Issue.
—
Highlights
|
Fresh off our Live Open Forum reviewing December 2024, we are welcoming 2025 with continued optimism that microcaps will continue to perform well, especially in certain industries. While we didn’t do a full year review as part of the forum, a few days earlier I was able able to sit down with Bobby Kraft of the Plant Microcap Podcast for a focused MicroCap Year-End Review in which we dissected key developments in the microcap space over the past year.
By the way, at one point during my conversation with Bobby, I talked about the differences and similarities between Geoinvesting and the Microcap Investing Cliff Note Substack. I get a lot of questions on that subject, so I thought the year-end review would be a great time to touch on it.
My goal was to review the performance of microcap indexes and spotlight specific stocks where detailed research and information arbitrage gave us an edge in the market.
It also included an analysis of our growing interest in misunderstood sub-$1 stocks and how we are going all in in Information Arbitrage research to identify the companies that the market is unjustly ignoring.
We touched on recurring themes from 2024, and why a diversified portfolio of high-quality microcaps can deliver multibagger returns, without the risks that a concentrated strategy can pose.
This is a particularly important point for those investors that don’t have enough time to perform the deep dive analysis necessary to run a concentrated strategy, but still want exposure to the alpha-rich returns that only microcaps can offer. For example, the MS Microcap Quality Index (MSMqi), launched in February 2022, currently includes 106 stocks. As of November 2024, it has delivered 41 multi-baggers—a hit rate of 38.7% in just three years.
The podcast also highlighted our outlook for 2025, emphasizing our intent to maintain our focus on quality microcap stocks with large short and long term upside.
In addition to the broader themes discussed in the podcast, we visited information arbitrage case studies in specific microcap stocks like Tss, Inc. (NASDAQ:TSSI), Lifevantage Corporation (NASDAQ:LFVN), Acorn Energy, Inc. (OTCQB:ACFN), and Tat Technologies Ltd. (NASDAQ:TATT).
Tss, Inc. (NASDAQ:TSSI): From near failure to a $12+ stock (current ytd return of 4989%) driven by operational turnaround and AI data center market tailwinds. It took the market forever to price in changes management made that would allow the company to increase capacity by 10x.
Lifevantage Corporation (NASDAQ:LFVN): A multi-level marketing company leveraging an innovative GLP-1 product to reignite growth. It took the market about two months to figure out that the company was about to launch a natural GLP-1 solution with similar weight loss results as Ozempic, but without all the side effects.
Acorn Energy, Inc. (OTCQB:ACFN): Recent contract to monitor generators for a telecom company’s wireless tower infrastructure is game-changing. Plenty of information arbitrage still exists in the story.
Tat Technologies Ltd. (NASDAQ:TATT): Benefiting from adding recurring revenue streams by entering into long-term maintenance contracts with its aerospace customers.
For the complete discussion, watch the full video below:
~Maj Soueidan
Don’t Miss The drone list, and To gain Exposure to our expanded coverage on Our 1500+ Microcap Universe, Subscribe below.
Please don’t forget to consider supporting GeoInvesting with a premium subscription if you enjoyed this content, and want to see more of it. Complete this short survey to let us know you’re engaged and interested.
200+ multibaggers and counting
GeoInvesting is a premier research platform for microcap investors, dedicated to uncovering high-potential stock ideas in undervalued companies across various sectors. With over 30 years of investing experience, GeoInvesting has covered more than 1,500 equities, providing often actionable proprietary research. The platform has been instrumental in identifying 200+ multibagger stocks, and offers investors exclusive access to over 600 management interview clips, allowing for deeper due diligence and understanding of the microcap stocks, many of which make it to market-beating premium Model Portfolios. Join the GeoInvesting community for the best stock research and microcap insights to help you stay ahead in the market. To learn more about our Premium Services, go here.. (https://geoinvesting.com/premium-research/)
The post Unlocking Microcap Alpha: 2024 Highlights and 2025 Insights with Maj Soueidan & Bobby Kraft [GeoWire Weekly No. 169] appeared first on GeoInvesting.
Source: https://geoinvesting.com/unlocking-microcap-alpha-2024-highlights-and-2025-insights-with-maj-soueidan-bobby-kraft/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Online: | |
| Visits: | 1,667,308,732 |
| Stories: | 8,325,093 |
Whistler Blowers, Insiders
